SCHEMBL13745985

SCHEMBL13745985

CC(C)(C)[Si](C)(C)Oc1cc(C=O)ccc1CO

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.40
TRIM24 O15164 1/20 0.40
HPGD P15428 1/20 0.40
ALDH5A1 P51649 1/20 0.40
ABAT P80404 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
TRIM33 Q9UPN9 1/20 0.40
TSHR P16473 1/20 0.39
FDPS P14324 1/20 0.38
POLB P06746 1/20 0.38
AOX1 Q06278 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MAPT P10636 2/20 0.36
NPC1 O15118 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
DRD2 P14416 1/20 0.35
KDM4E B2RXH2 3/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9452801 0.84 POLB (0.38) ALDH1A1TRIM24HPGDALDH5A1ABAT
SCHEMBL36740 0.82 ALDH1A1 (0.50) ALDH1A1TRIM24HPGDALDH5A1ABAT
SCHEMBL30360260 0.82 ALDH1A1 (0.50) ALDH1A1TRIM24HPGDALDH5A1ABAT
SCHEMBL14045435 0.81 ALDH1A1 (0.58) ALDH1A1TRIM24HPGDALDH5A1ABAT
SCHEMBL23245 0.79 ALDH1A1 (0.43) ALDH1A1TRIM24HPGDALDH5A1ABAT
SCHEMBL29234008 0.79 ALDH1A1 (0.43) ALDH1A1TRIM24HPGDALDH5A1ABAT
SCHEMBL17786208 0.79 PTGDR2 (0.39) ALDH1A1MAPTNPC1HTTRAB9A
SCHEMBL7565321 0.79 DRD2 (0.35) ALDH1A1TDP1TSHRSMN1; SMN2MAPT
SCHEMBL4493705 0.78 ALDH1A1 (0.46) ALDH1A1TRIM24HPGDALDH5A1ABAT
SCHEMBL498989 0.78 ALDH1A1 (0.64) ALDH1A1TRIM24HPGDALDH5A1ABAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7572778-B2 recognize and bind the tubulin site: antitubulin; useful for treating pathological states which arise from or are exacerbated by cell proliferation as anticancer and/or antiangiogenic activity SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2009-08-11 US disclosed